Overview Philips reported €18.0bn in full-year revenue for 2024, marking a 1% comparable sales growth, despite a double-digit decline in China. The company delivered strong cash flow and improved profitability, with an adjusted EBITA margin of 11.5% for the full year and 13.5% in Q4. CEO Roy Jakobs emphasized Philips’ resilience in navigating macroeconomic challenges,…
Overview Arista Networks delivered another record-breaking year in 2024, reporting $7.0bn in revenue, a 19.5% YoY increase, driven by strong demand for cloud networking, AI-powered solutions, and enterprise expansions. CEO Jayshree Ullal emphasized the company’s momentum, stating: “2024 was a remarkable year of momentum, resulting in a record $7 billion in revenue. We continued to…
Overview Cadence Design Systems closed 2024 with strong financial results, surpassing expectations for revenue and earnings. The company reported $4.64bn in total revenue, alongside a 42.5% non-GAAP operating margin. CEO Anirudh Devgan highlighted Cadence’s momentum in AI applications: “Our momentum continues to build as we exited 2024 with record bookings and record backlog. Cadence is…
Overview AppLovin Corporation delivered outstanding financial performance in Q4 and the full year of 2024, driven by its rapidly growing advertising business and strong profitability. The company recorded significant revenue and earnings expansion, reflecting the success of its AI-driven marketing platform. CEO Adam Foroughi stated: “Over the last few years, our team has achieved extraordinary…
Overview Crocs achieved a record-breaking performance in 2024, with annual revenues reaching $4.1bn. The company also reported exceptional operating cash flow, enabling significant share repurchases and debt reduction. CEO Andrew Rees highlighted the company’s robust growth, particularly within the Crocs brand, and noted the stabilization of HEYDUDE brand revenues: “Our fourth quarter performance exceeded expectations…
Overview Upstart Holdings delivered a strong Q4 2024 performance, achieving substantial revenue growth and near-GAAP profitability. CEO Dave Girouard highlighted the company’s expanding AI-powered lending marketplace, with significant improvements in loan originations, conversion rates, and operating efficiency: “In Q4 of 2024, our business grew dramatically across all product categories, delivered Adjusted EBITDA at levels not…
Overview Robinhood closed 2024 with record-breaking financial performance, reporting substantial growth across revenues, net income, and customer engagement. CEO Vlad Tenev emphasized the company’s rapid product innovation, highlighting the expansion into active trading platforms, the launch of the Robinhood Gold Card, and international expansion in the UK and EU. CFO Jason Warnick reinforced the company’s…
Overview Moody’s Corporation closed 2024 on a strong note, delivering 20% full-year revenue growth, driven by record issuance volumes and sustained demand for its analytics and risk management solutions. The company reported a 33% revenue increase in its Moody’s Investors Service (MIS) segment and 8% revenue growth in Moody’s Analytics (MA). President & CEO Rob…
Overview Edwards Lifesciences delivered strong financial and operational performance in 2024, driven by robust demand across its transcatheter heart valve therapies and structural heart innovations. Full-year revenue increased to $5.44bn, while Q4 revenue grew to $1.39bn, surpassing expectations. The company also made significant progress in clinical trials, positioning itself for continued growth in 2025 and…
Overview Shopify delivered a record-breaking year in 2024, with total revenue growing to $8.88bn, fueled by strong merchant momentum, international expansion, and increasing adoption of Shopify Payments and B2B solutions. The company crossed the $1tn milestone in cumulative GMV, highlighting Shopify’s dominance in the global e-commerce space. In Q4, revenue surged to $2.81bn, with free…
Overview monday.com delivered important financial results in 2024, with full-year revenue reaching $972m and surpassing $1bn in annual recurring revenue (ARR) for the first time. The company reported record non-GAAP operating income and free cash flow, driven by continued product innovation, strong customer expansion, and high retention rates. Co-CEOs Roy Mann and Eran Zinman stated:…
Overview Vertex Pharmaceuticals reported a 12% increase in full-year product revenue, driven by strong demand for TRIKAFTA®/KAFTRIO® and the successful global launch of new therapies. In Q4, revenue grew to $2.91bn, with U.S. net product revenue up 17% and international revenue rising 14%. The company also made significant regulatory progress, with the U.S. approval of…